Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alexion pharmaceuticals
biotech
boston
2
×
boston blog main
boston top stories
clinical trials
deals
life sciences
national blog main
alnylam pharmaceutials
amyotrophic lateral sclerosis (als)
arrowhead pharmaceuticals
autoimmune disorders
boehringer ingelheim
complement system
dicerna pharmaceuticals
eli lilly
fda
generalized myasthenia gravis
hepatitis b
immune-mediated necrotizing myopathy
indiana blog main
indiana top stories
johnson & johnson
national top stories
neurodegenerative diseases
primary hyperoxaluria
ra pharmaceuticals
rare disease drugs
rna interference
san francisco blog main
san francisco top stories
ucb
wisconsin blog main
wisconsin top stories
zilucoplan
What
deal
2
×
medicines
pharma
2
×
abandoning
ago
alternative
autoimmune
baggage
candidate
companies
cuts
development
dicerna
disease
drug
expensive
free
gets
interference
lead
long
pharmaceuticals
potential
ra
rna
rnai
signs
small
stakes
territory
ucb
viewed
wasn’t
world
Language
unset
Current search:
boston
×
deal
×
pharma
×
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
